Dr. Xiaoyu Wu brings over 33 years of extensive experience in accelerator R&D in U.S. National laboratories, universities, and private industries. His involvement spans the design, development, manufacturing, and operation of superconducting cyclotrons, rapid cycling synchrotrons, and superconducting linacs. At present, Dr. Wu is leading the R&D effort on cyclotron-based alpha emitter Actinium-225 and Astatine-211 productions at Ionetix. Since joining Ionetix in 2015, he has actively participated in the R&D of the Ion-12SC compact superconducting isochronous cyclotron for medical radioisotope production. Additionally, Dr. Wu has made significant contributions to K230 and SC240 superconducting cyclotrons for proton cancer therapy specifically designed for Pronova Inc. and HFCIM. Before his tenure at Ionetix, Dr. Wu was a senior accelerator physicist at the National Superconducting Cyclotron Laboratory (NSCL) and the Facility for Rare Isotope Beams (FRIB) at Michigan State University (MSU). Following the completion of his Ph.D. in Accelerator Physics from MSU, he worked at the Superconducting Super Collider Laboratory (SSCL). Dr. Wu earned his bachelor’s and master’s Degrees from Tsinghua University.